Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Fresenius Building China Dialysis Centers Network through Acquisitions

publication date: Dec 5, 2018

Germany's Fresenius Medical, a global company that makes renal care products and operates dialysis clinics, announced several acquisitions that will extend its China network of dialysis clinics. Fresenius claims to be the largest dialysis device maker and clinic operator in the world. It has been active in China since the early 1980s, operates four manufacturing sites in the country and is the market leader in parenteral nutrition, but Fresenius did not open its first China dialysis clinic until last year. More details....

Stock Symbol: (D: FMEG)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events


China Showcase 2020

San Francisco, USA

January 12, 2020

ChinaBio Partnering Forum 2020

Suzhou, China

May 6-7, 2020